HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gustavo Mostoslavsky Selected Research

IgA receptor (protein B)

10/2017Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gustavo Mostoslavsky Research Topics

Disease

5COVID-19
02/2022 - 01/2021
5Neoplasms (Cancer)
01/2020 - 05/2006
4Infections
01/2022 - 01/2008
2Sickle Cell Anemia (Hemoglobin S Disease)
11/2017 - 11/2016
2Aneuploidy (Aneuploid)
10/2014 - 04/2008
2Inflammation (Inflammations)
08/2007 - 02/2007
1Breakthrough Infections
01/2022
1Diarrhea
01/2021
1Nausea
01/2021
1Neurocognitive Disorders (Clerambault Syndrome)
12/2020
1Neuroinflammatory Diseases
12/2020
1Anastomotic Leak
01/2019
1Fetal Death
01/2018
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2017
1Acute Promyelocytic Leukemia
10/2017
1Insulin Resistance
11/2014
1Weight Gain
11/2014
1Down Syndrome (Down's Syndrome)
10/2014
1Proteostasis Deficiencies
01/2013
1Transthyretin-Related Hereditary Amyloidosis
01/2013
1Encephalitis (Encephalitis, Rasmussen)
11/2012
1Melanoma (Melanoma, Malignant)
03/2012
1Breast Neoplasms (Breast Cancer)
06/2011
1Endotoxemia
08/2007
1Severe combined immunodeficiency with sensitivity to ionizing radiation
10/2006
1Medulloblastoma
05/2006
1Genomic Instability
01/2006
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2005
1Lupus Nephritis
10/2005
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
06/2005
1Leukemia
06/2005
1Neointima
10/2004
1Multiple Myeloma
05/2004

Drug/Important Bio-Agent (IBA)

3AntibodiesIBA
02/2022 - 01/2021
3Proteins (Proteins, Gene)FDA Link
01/2008 - 05/2004
2Viral RNAIBA
01/2021 - 12/2020
2Immunoglobulin G (IgG)IBA
01/2021 - 01/2021
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 05/2004
2ChromatinIBA
01/2018 - 01/2006
2GlobinsIBA
11/2017 - 11/2016
2Fetal Hemoglobin (Hemoglobin F)IBA
11/2017 - 11/2016
2Small Interfering RNA (siRNA)IBA
04/2008 - 08/2007
2DNA (Deoxyribonucleic Acid)IBA
10/2005 - 06/2005
1Neutralizing AntibodiesIBA
01/2022
1mRNA VaccinesIBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Immunoglobulin M (IgM)IBA
01/2021
1CytokinesIBA
12/2020
1Biopolymers (Biopolymer)IBA
01/2019
1IgA receptor (protein B)IBA
10/2017
1Messenger RNA (mRNA)IBA
10/2017
1AdipokinesIBA
11/2014
1LipidsIBA
11/2014
1Pharmaceutical PreparationsIBA
10/2014
1Prealbumin (Transthyretin)IBA
01/2013
1Toll-Like Receptor 3IBA
11/2012
1Estrogens (Estrogen)FDA Link
06/2011
1rho GTPase-activating proteinIBA
08/2007
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2007
1PPAR alphaIBA
02/2007
1Angiogenesis InhibitorsIBA
02/2007
1Cyclin D2IBA
05/2006
1NestinIBA
05/2006
1Histone Deacetylases (Histone Deacetylase)IBA
01/2006
1AutoantibodiesIBA
10/2005
1Laminin (Merosin)IBA
10/2005
1Peptides (Polypeptides)IBA
10/2005
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2004
1InterleukinsIBA
05/2004
1Proto-Oncogene Proteins c-hckIBA
05/2004
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2004
1Phosphotransferases (Kinase)IBA
05/2004
1Tyrosine (L-Tyrosine)FDA Link
05/2004
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2004
1src-Family KinasesIBA
05/2004

Therapy/Procedure

3Therapeutics
11/2017 - 10/2006
1Highly Active Antiretroviral Therapy (HAART)
12/2020
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2007
1Transplantation
10/2006